                         SEQUENCE LISTING

<110>  THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW
       THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY OF
 
<120>  INSECT CONTROL AGENTS

<130>  007473648

<140>  PCT/EP2019/083553
<141>  2019-12-03

<150>  US 62/774,546
<151>  2018-12-03

<160>  25    

<170>  PatentIn version 3.5

<210>  1
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  conserved C-terminal pentapeptide motif


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = His, Asn, Ser or Tyr

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa = Ser, Pro or Ala

<400>  1

Phe Xaa Xaa Trp Gly 
1               5   


<210>  2
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-terminal motif

<400>  2

Trp Phe Gly Pro Arg Leu 
1               5       


<210>  3
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  C-terminal motif


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  3

Phe Xaa Pro Arg Leu 
1               5   


<210>  4
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = G or T

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa = I or V

<400>  4

Ala Xaa Ala Pro Arg Xaa Asx 
1               5           


<210>  5
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = G or T

<400>  5

Phe Xaa Cys Pro Arg Leu 
1               5       


<210>  6
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  6

Phe Thr Pro Arg Ile 
1               5   


<210>  7
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  7

Phe Lys Pro Arg Leu 
1               5   


<210>  8
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  8

Phe Thr Pro Arg Val 
1               5   


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = T with hydroxyproline (Hyp) side chain

<400>  9

Phe Xaa Arg Val 
1               


<210>  10
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = T with an Octahydroindole-2-carboxylic acid (Oic) side 
       chain

<400>  10

Phe Xaa Arg Val 
1               


<210>  11
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = I or V

<400>  11

Ala Thr Pro Arg Xaa 
1               5   


<210>  12
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  12

Ala Thr Pro Arg Ile 
1               5   


<210>  13
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide

<400>  13

Phe Gly Pro Arg Leu 
1               5   


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa = L, beta-homoleucine, beta-homoalanine or 
       beta-homo-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = V, beta-homoleucine, beta-homvaline, beta-homoalanine or 
       beta-homo-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa = A, beta-alanine

<400>  14

Ala Ser Gly Xaa Xaa Xaa Phe Pro Arg Val 
1               5                   10  


<210>  15
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa = L, beta-homoleucine, beta-homo-alanine or 
       beta-homo-phenylalanine

<400>  15

Ala Ser Gly Xaa Val Ala Phe Pro Arg Val 
1               5                   10  


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = V, beta-homoleucine, beta-homovaline, beta-homoalanine or 
       beta-homophenylalanine

<400>  16

Ala Ser Gly Leu Xaa Ala Phe Pro Arg Val 
1               5                   10  


<210>  17
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa = L or beta-homoleucine, beta-homo-alanine or 
       beta-homo-phenylalanine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa = A or beta-alanine

<400>  17

Ala Ser Gly Xaa Val Xaa Phe Pro Arg Val 
1               5                   10  


<210>  18
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa = beta-homoleucine

<400>  18

Ala Ser Gly Xaa Val Ala Phe Pro Arg Val 
1               5                   10  


<210>  19
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa = beta-homoleucine

<400>  19

Ala Ser Gly Leu Xaa Ala Phe Pro Arg Val 
1               5                   10  


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa = beta-homoleucine

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa = beta-alanine

<400>  20

Ala Ser Gly Xaa Val Xaa Phe Pro Arg Val 
1               5                   10  


<210>  21
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  kinin

<400>  21

Cys Asn Ser Val Val Leu Gly Lys Lys Gln Arg Phe His Ser Trp Gly 
1               5                   10                  15      


<210>  22
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CAPA-1

<400>  22

Gly Ala Asn Met Gly Leu Tyr Ala Phe Pro Arg Val 
1               5                   10          


<210>  23
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  labelled CAPA-1

<400>  23

Cys Gly Ala Asn Met Gly Leu Tyr Ala Phe Pro Arg Val 
1               5                   10              


<210>  24
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  kinin 1728


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa = F with alpha-aminoisobutyric acid (Aib) side chain

<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa = F with alpha-aminoisobutyric acid (Aib) side chain

<400>  24

Xaa Xaa Trp Gly 
1               


<210>  25
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Kinin 2139


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = F with alpha-aminoisobutyric acid (Aib) side chain

<400>  25

Phe Xaa Trp Gly 
1               


